Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study.
about
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control studyLymphoma incidence patterns by WHO subtype in the United States, 1992-2001Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia.Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.Temporal and demographic patterns of non-Hodgkin's lymphoma incidence in Pennsylvania.Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposure.Examining racial differences in diffuse large B-cell lymphoma presentation and survival.A systematic review of validated methods for identifying lymphoma using administrative data.Racial differences in mantle cell lymphoma in the United States.Incidence patterns and outcomes for hodgkin lymphoma patients in the United StatesSurvival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturationPrognostic significance of host immune gene polymorphisms in follicular lymphoma survival.Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study.The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada.Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality TrendsBody size in early life and risk of lymphoid malignancies and histological subtypes in adulthood.Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.Risk of lymphoma subtypes after solid organ transplantation in the United States.Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use.Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.Improvements in survival after follicular lymphoma by race/ethnicity and socioeconomic status: a population-based studyIncidence of first primary central nervous system tumors in California, 2001-2005.Racial differences in chronic lymphocytic leukemia. Digging deeper.Differences in incidence and trends of haematological malignancies in Japan and the United States.Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.Residential cancer cluster investigation nearby a Superfund Study Area with trichloroethylene contamination.Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.Using primary site as a predictor of survival in mantle cell lymphoma.Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis.Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States.Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study.Incidence and survival patterns of cutaneous T-cell lymphomas in the United States.Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma.
P2860
Q24683761-B0AF58EF-FEE6-4080-9425-9D71A1BFD7C2Q28271344-14C60D20-7280-4DC9-B493-2FDCFE06449EQ30479763-7FE4C43A-651E-417A-A9BB-085C45C74BC9Q33585882-6F7AD62E-BEE3-42A8-B5A1-723EB136BA2CQ33718809-8B42DFD6-6850-40C2-9426-A21665D4E1BCQ33956734-FBE7FEF3-242D-4DC8-B1A9-2A076AB14411Q34083951-E4796C12-A207-4D55-8F2C-C31DFD143574Q34117972-C68ABAB3-6F2E-42DC-ABCD-65741787817DQ34133911-3C9A2BA6-DC95-44E6-9C85-9B04A11FE986Q34410264-17E0FFE9-E092-4EF1-B868-AEA61AF2275CQ34442533-88CDD99B-1A85-4753-B8FA-2287A868DCD3Q34890475-C4CF7F13-B766-4DD5-8A7A-2590A37C4555Q35036813-E2857A4D-7C65-4436-87FB-2C3EE4ECB112Q35839898-67D952BF-5449-4300-A336-8870D5B95707Q36184245-73F2CF53-220A-4B20-BCF0-439331D4B2F2Q36191920-EFCDA0F2-6FC4-4408-9B50-78D0F30CB52CQ36463900-D3341DBB-0EA9-4C4F-8D17-2FCE270C11D9Q36866330-158E5D93-0B06-4357-9EC7-20D6A2A88A8FQ36924751-412B7339-B693-4FA2-93A6-063ACB544136Q37003308-E6679806-401C-4C5D-A98A-879B3E3BB18DQ37033240-46380B2A-63C7-4623-8DAA-21A0E6EE3B17Q37201934-65CF5ECC-CF1E-452C-8740-3615B86C6544Q37242294-D1E276F9-1853-4E77-925A-B421DA074004Q37299530-14DB688F-5A4F-41A3-A51B-CE3314B389EAQ37326806-07C4F9E7-3682-4B01-83AF-0AB1E0B209CBQ37535048-B6D73AB3-6242-499C-AF3C-E89656B19050Q38138170-6249244F-1D05-4A1D-8478-600DA1034083Q38674922-A6223DF6-79F0-48F3-9FD4-832188754CB8Q39372883-EBCC95E6-9580-4534-990D-3349ACD9A098Q39727079-DC612DF6-3182-4746-8CA4-4F2C2A33041BQ39915063-05C62487-3E6C-45BA-BCBC-E36AA03FBACCQ40163048-68E2D9A7-D5B1-4720-90CB-ED3A154DE326Q40411469-67C944A0-AF1D-4BBC-A86B-864C07C4DB44Q44105751-6A1B9B19-11C4-40E7-9296-C7424FB76A31Q45392865-997983CC-59DE-4494-8236-C0F3AB03AD46Q46236674-978EF047-70F1-402C-9612-F00EEEF30347Q46462344-CBCE7173-B9CD-406A-BD23-E218362398B1Q46778060-394732E4-EFDA-4FE4-8A4D-11234B0AFB96Q46786327-87548897-656D-4BCB-B5F9-918F8C0FDBEAQ47143348-BAFBC022-FB3B-4AB3-BBAF-99F0F85A2B77
P2860
Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Changes in cancer registry cod ...... ce for surveillance and study.
@ast
Changes in cancer registry cod ...... ce for surveillance and study.
@en
type
label
Changes in cancer registry cod ...... ce for surveillance and study.
@ast
Changes in cancer registry cod ...... ce for surveillance and study.
@en
prefLabel
Changes in cancer registry cod ...... ce for surveillance and study.
@ast
Changes in cancer registry cod ...... ce for surveillance and study.
@en
P2093
P1476
Changes in cancer registry cod ...... ce for surveillance and study.
@en
P2093
Dawn M Undurraga
Elizabeth A Holly
Lindsay M Morton
Patricia J Harasty
P304
P356
10.1158/1055-9965.EPI-05-0549
P577
2006-04-01T00:00:00Z